Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Renew Dental Diminishes Fear by Protecting Patients and Staff From COVID-19 Using Surfacide’s Proven UV Technology

FOR IMMEDIATE RELEASE Renew Dental is the first dental practice in the United States to adopt Surfacide–a powerful and innovative technology to combat COVID-19 head on and provide a safer environment for patients and staff. The leading Phoenix dental facility is using Surfacide’s proven UV-C system to decontaminate surfaces to address the concerns of SARS-CoV-2…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Renew Dental Diminishes Fear by Protecting Patients and Staff From COVID-19 Using Surfacide’s Proven UV Technology

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

FOR IMMEDIATE RELEASE

Renew Dental is the first dental practice in the United States to adopt Surfacide–a powerful and innovative technology to combat COVID-19 head on and provide a safer environment for patients and staff. The leading Phoenix dental facility is using Surfacide’s proven UV-C system to decontaminate surfaces to address the concerns of SARS-CoV-2 and COVID-19.

Staff at Renew Dental were pleasantly surprised to see the technology at work, decontaminating patient rooms in as little as five minutes. Dr. Gwen Multine, DMD, discovered the Surfacide system when researching UV technology and knew her patients and workers would be appreciative in the dental practices’ investment in their safety.

“Our office is perfect for the Surfacide system. When the pandemic began, we were looking for something that would not just give the illusion of safety or spray chemicals into the air,” says Dr. Gwen Multine. “Surfacide accomplishes that while making our patients and technicians feel safer.”

Surfacide is being used to decontaminate rooms daily and Renew Dental has not reported any positive COVID-19 cases since its implementation. Each day, Renew Dental’s EVS team runs Surfacide in the exam rooms, cleans the space by hand and runs the Surfacide system once more for an additional layer of protection. The Surfacide system is the first of its kind to use a triple emitter UV-C technology to laser map the room and significantly reduce the presence of viruses and bacteria in a single, rapid cycle.

“Renew Dental is a unique partner of ours as they are the first dental office in the U.S. to implement Surfacide’s technology, and we are very impressed with their proactive infection prevention initiatives to address COVID-19,” says Gunner Lyslo, Founder and CEO of Surfacide. “COVID-19 has made critical healthcare tasks like visiting the dentist something that many may delay doing for fear of the current pandemic. Surfacide and clinics like Renew dental are here to reduce that fear and provide a sense of normalcy back to everyday life.”

About Surfacide LLC

Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.

Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients

and healthcare workers. Surfacide’s evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.

Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.

For More Information Contact

Sarah Kotlan | Marketing Coordinator Surfacide, LLC (262) 501-4900 | sarah.kotlan@surfacide.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

July partnerships show hospitals aligning without ownership change

July partnerships show hospitals aligning without ownership change

A July McDermott Will & Schulte analysis and four July partnership announcements tracked by Becker’s Hospital Review point to affiliation models that stop short of mergers. St. Christopher’s signed a nonbinding letter of intent with Nemours, Jefferson and Temple; Palomar UC San Diego Health began operating July 1 under a joint powers authority. Several announcements explicitly rule out ownership change, shifting the work to contracts covering governance and other terms.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Eye telemedicine hits limits without home retinal imaging

Eye telemedicine hits limits without home retinal imaging

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512